Moderna Soars as Barron's Highlights Its Value
Moderna stock skyrockets, leading the S&P 500 after Barron's names it a top 2025 pick, citing it as 'too cheap' to ignore. Discover why it's a must-watch.
Moderna was the best-performing stock in the S&P 500 as Barron's called it 'too cheap' and named it a top 10 pick for 2025.